| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/29/2006 | WO2006069196A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | WO2006068904A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 06/29/2006 | WO2006068770A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 06/29/2006 | WO2006068594A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | WO2006067444A1 Amide derivatives |
| 06/29/2006 | WO2006067428A2 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 06/29/2006 | WO2006067385A1 Chemical compounds |
| 06/29/2006 | WO2006067311A2 Cdc25 phosphatase inhibitors |
| 06/29/2006 | WO2006067086A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 06/29/2006 | WO2006066968A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | WO2006066948A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066929A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | WO2006066928A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142584 Epothilone side components |
| 06/29/2006 | US20060142575 Hetereoaryl nitrile derivatives |
| 06/29/2006 | US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 06/29/2006 | US20060142568 Method for the production of bicyclic aromatic amino acids and intermediate products thereof |
| 06/29/2006 | US20060142369 Delta 1-pyrrolines used as pesticides |
| 06/29/2006 | US20060142365 Benzimidazole compounds and antiviral uses thereof |
| 06/29/2006 | US20060142360 Having a central trivalent nitrogen atom to which is attached either direct or indirectly three ring systems, at least one of which is substituted by a sulfamate group and one by a halogen; steroid sulfatase and aromatase inhibitors |
| 06/29/2006 | US20060142357 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142345 3,5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 06/29/2006 | US20060142343 Pyrrolines |
| 06/29/2006 | US20060142334 Tetrahydroquinoline derivatives |
| 06/29/2006 | US20060142329 Substituted fused N-heteroaryl compounds such as imidazo[1,5a]- or [1,2s]pyridines, e.g., 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity and type 2 diabetes |
| 06/29/2006 | US20060142328 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142327 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142293 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 06/29/2006 | US20060142284 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis |
| 06/29/2006 | US20060142281 Indolinone derivatives |
| 06/29/2006 | US20060142280 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | US20060141395 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 06/29/2006 | CA2592464A1 Tricyclic .delta.-opioid modulators |
| 06/29/2006 | CA2592462A1 Tricyclic delta-opioid modulators |
| 06/29/2006 | CA2592442A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | CA2592378A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | CA2591766A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 06/29/2006 | CA2591215A1 Cdc25 phosphatase inhibitors |
| 06/29/2006 | CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | CA2589133A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | CA2584295A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 06/28/2006 | EP1674466A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
| 06/28/2006 | EP1674460A1 Chromene compound |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673370A1 A novel crystalline form of linezolid |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673081A1 Indoles and azaindoles as antiviral agents |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795192A Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 06/28/2006 | CN1795191A 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 06/28/2006 | CN1795181A Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795178A Process for synthesizing heterocyclic compounds |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1794997A 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | CN1793141A Process for synthesizing 5,5' bit connected 1,1'-diphenyl kind axle chirality ligand |
| 06/28/2006 | CN1793140A 5,5' bit connected 1,1'-diphenyl kind axle chirality ligand |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261419C Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 06/28/2006 | CN1261418C 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067662 CXCR3 antagonists |
| 06/27/2006 | US7067656 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 06/27/2006 | US7067655 Adenosine A2a receptor antagonists |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067513 Phenylpiperazines |
| 06/27/2006 | US7067509 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006066173A2 Novel mch receptor antagonists |
| 06/22/2006 | WO2006065872A1 Piperazinyl-pyridine analogues |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |